MEDPLUS Share Price Performance
₹801.30
-105.25 (-11.61%)
31.4% undervalued intrinsic discount
₹1,168.71
Fair Value
Price ₹801.30
AnalystConsensusTarget ₹1,168.71
Fair Value₹1,168.71
Share Pricen/a
Narrative Update • Jun 25
MedPlus Health Services Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
MEDPLUS Community Narratives
AN
Fair Value
·Fair Value ₹1.17k 31.4% undervalued intrinsic discount
Diagnostics Expansion And Private Labels Will Strengthen Market Position
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
Diagnostics Expansion And Private Labels Will Strengthen Market Position
MedPlus is betting on a bigger pharmacy network, more in-house products, and faster deliveries to grow across India, while also building out its diagnostics business. The key question is whether that expansion stays disciplined enough to avoid stock build-ups and margin pressure from cheaper own-brand sales.Read more
AN
₹1.17k
31.4% undervalued intrinsic discount
Fair Value
Revenue
15.4% p.a.
Profit Margin
3.12%
Future PE
60.53x
Price in 2029
₹1.65k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
MEDPLUS: Upcoming AGM And ESOP Allotment Will Support Bullish Repricing
Fair Value: ₹1.17k 31.4% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
MedPlus Health Services Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 21, 2026
- 18.28
- 26.23%
- 3.19%
- 0%
About MEDPLUS
- Founded
- 2006
- Employees
- 25007
- CEO
- WebsiteView website
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
Recent MEDPLUS News & Updates
Narrative Update • Jun 04
